PHASQ — PhaseBio Pharmaceuticals Cashflow Statement
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
- $0.00m
- -$3.73m
- $10.83m
Annual cashflow statement for PhaseBio Pharmaceuticals, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2017 December 31st | 2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -10.2 | -23.8 | -39.2 | -98.6 | -131 |
| Depreciation | |||||
| Non-Cash Items | 1.83 | 4.66 | 1.92 | 42.4 | 52.5 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 0.066 | 2.03 | -2.44 | -4.26 | 29.4 |
| Change in Accounts Receivable | |||||
| Change in Prepaid Expenses | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | -8.26 | -17.1 | -39.6 | -60 | -47.4 |
| Capital Expenditures | -0.216 | -0.119 | -0.96 | -1.41 | -2.68 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | 0 | — | — | — | — |
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -0.216 | -0.119 | -0.96 | -1.41 | -2.68 |
| Financing Cash Flow Items | — | — | -0.145 | 15 | 8.14 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 18.2 | 64.8 | 53.5 | 15.5 | 63.8 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 9.69 | 47.6 | 13 | -45.9 | 13.7 |